HPV

Laser-activated eye cancer drug developer Aura Biosciences scores $40M in Medicxi-led round
Laser-activated eye cancer drug developer Aura Biosciences scores $40M in Medicxi-led round
Endpoints
Aura Biosciences
HPV
eye cancer
Medicxi
Flag link:
'Unprecedented' demand for Merck's Gardasil drives monster Q3
'Unprecedented' demand for Merck's Gardasil drives monster Q3
Fierce Pharma
Merck
earnings
Gardasil
vaccines
HPV
Flag link:
Gardasil HPV Vaccine Approved for Use in Adults Up to Age 45, But Will This Age Group Get the Shot?
Gardasil HPV Vaccine Approved for Use in Adults Up to Age 45, But Will This Age Group Get the Shot?
Xtalks
Merck
vaccines
HPV
Gardasil 9
Flag link:
FDA expands use of an HPV vaccine up to age 45
FDA expands use of an HPV vaccine up to age 45
Stat
FDA
Gardasil 9
Merck
HPV
vaccines
Flag link:
HPV-related cancer rises, despite higher vaccination rates
HPV-related cancer rises, despite higher vaccination rates
Bizjournals.com
vaccines
HPV
cervical cancer
Merck
Gardasil
Flag link:
No Ovarian Failure Risk After HPV Vaccine, Study Finds
No Ovarian Failure Risk After HPV Vaccine, Study Finds
Forbes
vaccines
HPV
Gardasil
Merck
CDC
primary ovarian insufficiency
Flag link:
Roche is on the “SurePath” for Cervical Cancer Screening with Approval
Roche is on the “SurePath” for Cervical Cancer Screening with Approval
Medical Devices and Diagnostics Industry
Roche
FDA
HPV
SurePath
diagnostics
Flag link:
Despite high-flying Gardasil sales, Merck executives see 'significant' opportunity ahead
Despite high-flying Gardasil sales, Merck executives see 'significant' opportunity ahead
Fierce Pharma
Merck
Gardasil
vaccines
HPV
Flag link:
U.K. to offer Merck's Gardasil to boys after years of protests
U.K. to offer Merck's Gardasil to boys after years of protests
Fierce Pharma
UK
Merck
Gardasil
HPV
vaccines
Flag link:
HPV Vaccine Works to Reduce Abnormal Cells in Cohort of Women
HPV Vaccine Works to Reduce Abnormal Cells in Cohort of Women
Xtalks
vaccines
HPV
cervical cancer
Gardasil
Merck
Denmark
Flag link:
Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize DNA Immunotherapy product (VGX-3100) in Greater China
Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize DNA Immunotherapy product (VGX-3100) in Greater China
CP Wire
Inovio
China
ApolloBio
VGX-3100
DNAi-based therapeutics
HPV
Flag link:
Inovio lands $23m in collab with ApolloBio for HPV immunotherapy
Inovio lands $23m in collab with ApolloBio for HPV immunotherapy
Drug Delivery Business News
Inovio
ApolloBio
HPV
immunotherapy
Flag link:
HPV Vaccination Immunity Remains Strong 10 Years Later, Especially For Preteens
HPV Vaccination Immunity Remains Strong 10 Years Later, Especially For Preteens
Forbes
vaccines
HPV
Merck
Gardasil
Flag link:
Merck's Gardasil 9 offers at least 6 years of cancer protection, data show
Merck's Gardasil 9 offers at least 6 years of cancer protection, data show
Fierce Pharma
Merck
Gardasil 9
vaccines
HPV
cervical cancer
Flag link:
HPV vaccination rates ticking upward, CDC says as it urges more uptake
HPV vaccination rates ticking upward, CDC says as it urges more uptake
Fierce Pharma
vaccines
HPV
CDC
Merck
Gardasil
Flag link:
HPV Infection Rates Plummet With Vaccination
HPV Infection Rates Plummet With Vaccination
Forbes
HPV
vaccines
cervical cancer
Gardasil
Merck
Flag link:
Inovio launches late-stage cervical dysplasia trial after FDA lifts hold
Inovio launches late-stage cervical dysplasia trial after FDA lifts hold
Drug Delivery Business News
Inovio
cervical dysplasia
FDA
clinical trials
HPV
Cellectra
devices
Flag link:
New study could boost vaccination argument for Merck's Gardasil
New study could boost vaccination argument for Merck's Gardasil
Fierce Pharma
vaccines
Merck
HPV
Gardasil
Flag link:
This Survey's Bad News Could Be Good News for Inovio Pharmaceuticals
This Survey's Bad News Could Be Good News for Inovio Pharmaceuticals
Motley Fool
Inovio
VGX-3100
HPV
cervical cancer
Flag link:
This Is Driving Merck’s Vaccines Business
This Is Driving Merck’s Vaccines Business
Market Realist
Merck
vaccines
Gardasil
HPV
Flag link:

Pages